Trametinib inhibits lymphatic vessel invasion of bone in a mouse model of Gorham-Stout disease.
Anna L McCarterMichael T DellingerPublished in: Journal of vascular anomalies (2023)
mice. These findings further support the testing of MEK inhibitors in patients with GSD and other RAS pathway-driven complex lymphatic anomalies with bone involvement.